Aytu Biopharma (AYTU) Net Income towards Common Stockholders (2010 - 2026)
Aytu Biopharma's Net Income towards Common Stockholders was -$15,000 in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$19.82 million a year earlier.
Powered by 
Analysis
Aytu Biopharma (AYTU) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Net Income towards Common Stockholders at Aytu Biopharma came in at -$14.25 million.
- In earlier fiscal years, Net Income towards Common Stockholders was -$13.56 million in FY2025, -$15.84 million in FY2024, -$17.05 million in FY2023 and -$108.8 million in FY2022.
- Quarterly Net Income towards Common Stockholders has moved between -$53.29 million (fiscal Q3 2022) and $3.99 million (fiscal Q3 2025) over five years.
- Per Business Quant data, AYTU's Net Income towards Common Stockholders in the three fiscal quarters before Q4 2026 was -$5.62 million (Q3 2026), -$10.58 million (Q2 2026) and $1.97 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Aytu Biopharma | 22.49 Mn | -93.18 Mn | 10.41 Mn | -15,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15,000.00 |
| Mar 31, 2026 | -5.62 Mn |
| Dec 31, 2025 | -10.58 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | -19.82 Mn |
| Mar 31, 2025 | 3.99 Mn |
| Dec 31, 2024 | 788,000.00 |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | -4.62 Mn |
| Mar 31, 2024 | -2.89 Mn |
| Dec 31, 2023 | -220,000.00 |
| Sep 30, 2023 | -8.12 Mn |
| Jun 30, 2023 | -2.46 Mn |
| Mar 31, 2023 | -7.20 Mn |
| Dec 31, 2022 | -6.69 Mn |
| Sep 30, 2022 | -701,000.00 |
| Jun 30, 2022 | -16.11 Mn |
| Mar 31, 2022 | -53.29 Mn |
| Dec 31, 2021 | -11.55 Mn |
| Sep 30, 2021 | -27.85 Mn |
API Access
Aytu Biopharma Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();